Who

​Robert Colebunders​

MD, PhD, Professor Emeritus, Department of Epidemiology and Social Medicine, Faculty of Medicine and Health Sciences, University of Antwerp. Until 2014, Prof Colebunders was Head the Clinical HIV/STD Unit at the Antwerp Institute of Tropical Medicine (ITM). He worked in Algeria (1974-76, primary health care and public Health), the Democratic of Congo (1985-87, Kinshasa, Projet SIDA), US (1988, CDC, Atlanta) and Uganda (2003-4, Infectious Diseases Institute, Makerere University). His main expertise and research interest is in HIV, tuberculosis and hemorrhagic fever. He initiated the international network for the study of HIV related immune reconstitution inflammatory syndrome (INSHI). He was a member of the international team that investigated the Kikwit Ebola and the Durba Marburg outbreak. During his career, Prof Colebunders published over 500 articles in peer-reviewed journals. Currently, his academic focus is on research to identify the cause of the nodding syndrome and river epilepsy in onchocerciasis endemic regions.
The last years he investigated the link between onchocerciasis and epilepsy. We showed that onchocerciasis-associated epilepsy (OAE) is a major unrecognized public health problem in many onchocerciases endemic regions in Africa where there is weak onchocerciasis control. We discovered that nodding syndrome (NS) and the Nakalanga syndrome are two of the most severe forms phenotypic presentations of OAE characterised by a high level of Onchocerca volvulus microfilarial load. In several retrospective and longitudinal studies we showed that strengthening an onchocerciasis elimination programme can decrease the incidence of epilepsy including NS in onchocerciasis endemic areas. We showed that a cheap community based “Slash and Clear” vector control method was highly effective in decreasing blackfly biting rates. Recently using viral metagenomics we identified a rhabdovirus in the O. volvulus worm and in the blackflies. Showing that this virus could play a role in the pathogenesis of OAE is now our main research objective. We are also involved in collaborative research to identify more sensitive and specific rapid test to identify O. volvulus antibodies.

​Jean-Pierre Van geertruyden​

Prof Van geertruyden is a professor Global Health. He has worked over a decade as a clinician and manager in humanitarian and disease control projects of the World Health Organization and Médecins Sans Frontières (MSF), mainly in Sub Saharan Africa. His academic career started at ITM Antwerp in 2003, where he was involved in malaria and HIV research. Since 2009, he works at the University of Antwerp. His main expertise lies in bio-statistical support, designing and implementing Epidemiological study designs and conducting clinical trials (Phase 1-2-3-4). (Development of) molecular tools and social sciences are incorporated in the majority of his studies. Apart from Malaria related research (main expertise), he has set up research lines on NCDs, cancer diagnosis & treatment, vaccine development, etc. with colleagues with complementary expertise. Ongoing collaborations in DRCongo, Zambia, Tanzania, Burundi, Uganda, Peru, Ethiopia, Kenya, Mozambique, where he mainly works on malaria and human papilloma virus (HPV) research.

​Annelies Van Rie​

Prof Annelies Van Rie is a pediatrician and epidemiologist with over 25 years extensive experience in clinical, epidemiological, and translational research of tuberculosis (TB) that have resulted in over 230 scientific papers published in peer reviewed scientific journals including NEJM, Lancet and Plos Medicine. After moving from the University of North Carolina Chapel Hill in the USA to the University of Antwerp in 2015, she successfully established the multidisciplinary Tuberculosis Omics ResearCH group (TORCH, https://torch-consortium.com). The mission of the centre is to increase the implementation of WGS into routine diagnosis, treatment, and prevention of TB. In the past 8 years she has, together with her team in Antwerp and at the University of Stllenbosch in South Africa, laid the groundwork to overcome several important challenges that hinder the use of WGS in routine care. Between 2016 and 2022, her team developed and validated MAGMA, a novel bioinformatics pipeline specifically designed to overcome the challenge associated with the analysis of clinical samples that are typically paucibacillary and contaminated. Since 2021, she lead the SMARTT trial, a pragmatic clinical trial aimed to assess the effectiveness of WGS sequencing of rifampicin resistant TB isolates coupled with an automated treatment recommendation, a highly novel user-friendly application designed using machine learning methods.

​Erika Vlieghe

Professor Erika Vlieghe is an Infectious Diseases clinician with professional experience within and outside Belgium (UK, Uganda, Ecuador, Cambodia). She studied medicine at the Leuven Catholic University (1996), Tropical Diseases at the Antwerp Institute of Tropical Medicine (ITM, 1997) and specialized in internal medicine and infectious diseases at the Leuven Catholic University (2004).

From 2004-2017 she has been working as a senior staff member and researcher at the ITM. Since 2017 she is heading the Department of General Internal Medicine, Infectious Diseases and Tropical Medicine at the University Hospital of Antwerp (UZA); she teaches tropical medicine and infectious diseases at various undergraduate and postgraduate courses at the University of Antwerp and the ITM. Over the past few years she has been involved in research and capacity building on antibiotic resistance; she obtained a Phd on blood stream infections in Cambodia in 2014. From October 2014 – October 2015 Erika Vlieghe was appointed 'National Ebola-coördinator' in Belgium. Since the beginning of the COVID-19 crisis she has been heading several scientific committees advising the federal government on pandemic management and preparedness. Since 2022 she is also a member of the Royal Flemish Academy of Medicine and the president of the Flemish Recognition Board for Clinical Infectiology. On November 23d, she was appointed to coordinate the scientific advice underlying the National Sepsis Plan. She is currently the (co)-promotor of 5 research projects, and supervising 6 PhD-students. In 2020, she was awarded the ‘Gold medal’ from the Royal Academy of Arts and Sciences, and in 2023,she received an honorary doctorate from the University of Hasselt for her enduring scientific advisory function with public health policy during the COVID-19 pandemic. Her main research interests include interventions for antimicrobial stewardship, pandemic preparedness and the role of professional education in these fields.

​Steven Abrams​

Prof. Abrams holds a bachelor degree in mathematics (2009), a master degree in statistics (Epidemiology and Public Health Methodology) (2011) and a PhD degree in statistics (2015) from Hasselt University. He has worked on modelling individual heterogeneity in the acquisition of infectious diseases using frailty models. His primary research interest is in the quantification of unobserved heterogeneity in susceptibility to infection, infectiousness upon infection and social contact behavior, sources which are all relevant for the spread of infectious diseases and the control of emerging infections. Furthermore, his research interests include the statistical analysis of (serial-) serological survey data, outbreak risk assessment in highly vaccinated populations (including but not limited to measles, mumps and rubella), development of novel statistical methodology for the estimation of epidemiological parameters with regard to malaria infection and the application and integration of survival data techniques in infectious disease epidemiology. Prof. Abrams teaches introductory topics in statistics and mathematical modelling in the Bachelor of Mathematics and Biomedical Sciences at Hasselt University, in the Bachelor of Medicine at the University of Antwerp and to master students in Biomedical Sciences at Hasselt University. He also gives advanced statistical courses and statistical consultancy training in the Master of Statistics at Hasselt University and the Master of Epidemiology at the University of Antwerp.

​Yves Jacquemyn​

MD, PhD - Prof Jacquemyn is the Head of the Department of Obstetrics and Gynecology at the UZA. He started his research on ethnic differences in perinatal outcome, fetal growth and uteroplacental circulation in Flanders, Belgium. Later this moved more to socioeconomic differences. His actual major research topics are on maternal health as co-founder of the Antwerp Female Heart Team, pre-eclampsia and fetal monitoring besides pelvic floor and benign gynecologic surgery. He has served several times as an ultrasound teacher and as a surgical trainer in Africa. He has been coordinator for the specialist training at Anwterp University from 2004 to 2022; coordinates the interuniversity course on Obstetric Interventions since 2005, has cofounded the interuniversity postgraduate on Fetal Ultrasound and Medicine since 2016, coordinates the interuniversity training on fetal monitoring since 2010.

He is director of the ZSG ( zorgcentrum na seksueel geweld) -Antwerp. He has been involved in several interuniversity research projects on fetal surgery. As member of the Antwerp university hospital UZA he has taken parts in several grants including 2018 TBM T004018N PREMOM II: pregnancy remote monitoring of women at risk for gestational hypertensive disorders ( co-applicant) and 2022 TBM T004422N Prenatal valaciclovir-treatment for congenital CMV: a prospective cohort study
He is currently starting up the Belgian part of the TWIN-C trial ( on cerclage in twin pregnancies) with Amsterdam university) and the SAVE FGR trial (on heart rate variability in fetal growth restriction( also with Amsterdam university) and is promoting a new PhD on metranl health in Arba Minch region Ethipoia together with Prof Veerle Draulans, sociologist and another one in Uganda on a neonatal intervention package to decrease neonatal mortality.

José Luis Peñalvo​

Dr. Peñalvo is a Full Professor at the University of Madrid (espana), where he leads the Unit of Non-communicable Diseases (NCDs) and a Professor of Epidemiology at the University of Antwerp. He is an epidemiologist and public health specialist with a strong background in quantitative research and epidemiologic methods, including the design, and outcome and impact evaluation of primary prevention interventions, and estimating health impacts through modelling the effect of population-based dietary policies to reduce NCD-related burdens. Throughout his career, he had the opportunity to address all levels of chronic NCD prevention, from primordial to tertiary, from developing strategies to instill appropriate lifestyle behaviors in small children, to population-based studies to reduce the prevalence of NCD risk factors, to refining treatments and reduce disabilities among chronic disease patients. He has been central in the process- and impact-evaluation of a nation-wide, intra-curricular school-based intervention to encourage healthy lifestyles and behaviors in children (N~2,400) aged 3-5. He has led the study of the psychosocial, dietary and physical activity habits of participants from two large prospective cohorts (N~10,000) studies dedicated to identifying the determinants of plaque formation and the onset of atherosclerotic disease using state-of-the-art imaging to assess the burden in several territories in asymptomatic individuals. Dr Peñalvo is interested in a life-course approach to health and disease, through the analysis of the long-term effects that biological, physical and social exposures during childhood, adolescence, young adulthood and later adult life, may have on the development of chronic disease.

​Hilde Bastiaens​

​MD, PhD - Hilde Bastiaens is professor at the Centre for primary care medicine, Department of Interdisciplinary and Primary Care. Her research interest lies in primary care, chronic non-communicable disease management and health systems research. Prof. Bastiaens presides the University Center of Qualitative Health Research Antwerp. She is also is co-investigator of the Institutional University Cooperation between the University of Limpopo and the Flemish Universities (PI Prof Van geertruyden). As part of this large project, she leads a chronic disease management study in rural Limpopo. She and Prof. Van geertruyden collaborate with Prof. Nuwaha, Fred Prof. Rhoda Manyenze in Uganda and Prof. Ndikubagenzi in Burundi on chronic disease management and qualitative research components.​

​Sibyl Anthierens​

Prof. dr. Sibyl Anthierens is a social scientist at the Department of Family Medicine and Population health.  She is co-leading Qualua together with prof dr Hilde Bastiaens (the University Center of Qualitative Health Research Antwerp). Her specific role and research aims are coordinating and looking for strategic opportunities to deliver cross-cutting social science research across clinical and epidemiological work in infectious diseases research to evaluate how evidence based treatment and management strategies are used or not used in everyday practice by patients and professionals in primary care and how this new evidence can be used to improve practice by tailoring interventions, evaluate and adapt them and implement them in practice. She has used a wide range of research methodologies, but with a particular focus on qualitative research.  She supports several national and international PhD students on the qualitative research components of their research.

Hans Keune​

Hans Keune is a Political Scientist (University of Amsterdam) with a PhD in Environmental Sciences (University of Antwerp). ORCID: He works on critical complexity, inter- and transdisciplinarity, action research, expert elicitation, decision support methods and integrated approaches; environment & health, ecosystem services, biodiversity & health, One Health/EcoHealth; experience both in Belgian projects and EU-projects. Until October 2010 his expertise was mainly related to his work for the Centre of expertise for Environment and Health in which he has been involved from the start in 2002 as principal investigator of the social scientific research unit of the Centre. At the Faculty of Medicine and Health Sciences of the University of Antwerp he currently coordinates the chair ‘Care and the Natural living environment’ as professor. He is also affiliated to the Faculty of Applied Economics, University of Antwerp where he collaborates on decision support systems such as multi-criteria decision analysis and group decision support. He is coordinator of the Belgian One Health Network. He is member of the Belgian delegation to the Intergovernmental Platform on Biodiversity and Ecosystem Services (IPBES), was member of the IPBES Expert Group on the ‘diverse conceptualizations of values of biodiversity and nature’s benefits to people including ecosystem services’ and Lead Author on the IPBES Regional Assessment Europe – Central Asia where he coordinated the review work in relation to nature – health linkages. He is also co-initiator of the Network for EcoHealth and One Health (NEOH) – European chapter of EcoHealth International.

​Christopher Delgado Ratto​

Christopher Delgado Ratto is a professor of Molecular Epidemiology at the University of Antwerp in Belgium. Christopher graduated as a biologist in Peru and then followed postgraduate studies in Belgium in Molecular Biology and Epidemiology and a Ph.D. in Medical Sciences. Christopher has an extensive experience in the molecular epidemiology of malaria. His projects are based in Peru, Africa, and Southeast Asia. His primary interest is integrating epidemiology with population genetics and phylogenetics to investigate infectious diseases and support malaria elimination programs through capacity building and joint research. He is currently studying the malaria transmission dynamics at a country/regional and individual level, improving the assessment of antimalarial treatments by understanding the genetic background of malaria parasites, unraveling the contribution of human mobility to malaria persistence, and genomic surveillance of drug resistance. Christopher is leading malaria mixed research methods projects in Peru, collaborating with local universities and the national malaria elimination program. Christopher is also working on genomic surveillance of SARS-CoV-2 in Peru and African countries. Besides research, Christopher is co-coordinating the Malaria Research group (MaRch) at UAntwerp, a guest professor at the Free University of Brussels, an adjunct principal researcher at Universidad Peruana Cayetano Heredia in Peru, and co-founder of the GENMAL network.

Nele Brusselaers​

Nele has extensive experience in clinical, cancer and pharmaco-epidemiology by working with the Swedish nationwide health registries, several clinical cohorts and systematic reviews and meta-analyses. Although she has a broad interest and experience in different clinical topics (incl. infectious diseases) with many international collaborations. One of her main interests is to investigate the long-term effects of commonly prescribed drugs (incl. antibiotics, proton pump inhibitors) on health, through potential drug-mediated alterations of the microbiome.

Tim Heupink​

PhD, postdoctoral fellow, Department of Epidemiology and Social Medicine, Faculty of Medicine and Health Sciences. Tim is an evolutionary geneticist with an interest in Next Generation Sequencing and real-time evolutionary dynamics across space and time. He applies these principles to study tuberculosis as part of the Center for Whole Genome Sequencing of Mycobacterium tuberculosis.

​Joseph Nelson Siewe​

Dr. Siewe is a research physician interested in tropical neurology. He is currently carrying out his PhD research with the NSETHIO group of the Global Health Institute, whose main aim is to better understand onchocerciasis-associated epilepsy and provide prevention/management options in affected communities. He actively participated in the organization of the 1st International Workshop on Onchocerciasis-Associated Epilepsy (OAE) in 2017, and is part of the OAE Alliance. He has cumulated field experience in several African countries including Cameroon, Nigeria and the Democratic Republic of Congo, and laboratory experience from the Biotechnology Center of the University of Yaoundé I, Cameroon.

Anzaan Dippenaar​

PhD (Stellenbosch University, South Africa), postdoctoral fellow, Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences. Anzaan is a molecular biologist and has an interest in applying Next-Generation sequencing (NGS) to study Mycobacterium tuberculosis. She applies various approaches to investigate the microevolution of M. tuberculosis during transmission, study mycobacterial genomics of treatment response during tuberculosis disease, and explore the genomic characteristics of various mycobacterial strains causing tuberculosis in a variety of animal host species. Anzaan is also heavily involved in NGS capacity building, especially as part of collaborations with partners in Sub-Saharan African countries. 

​Roma Siugzdaite

Dr. Siugzdaite holds a bachelor degree in mathematics and informatics, a master degree in mathematics and a PhD degree in Computer science from Vytautas Magnus University, Lithuania. She has worked on modelling brain development using generative models. Her primary research interest is in environmental and genetic effects on neurodevelopment and how they effect education and mental health. Furthermore, her research interests include the statistical analysis of behavioural, brain and survey data, network analysis, etc. Dr. Roma Siugzdaite teaches introductory topics in statistics StatUA and FLAMES for PhD students from University of Antwerp and other universities in Flanders.

​Annelies Mondelaers

Dr. Mondelaers is a holder of master's degree in Biomedical (2007) and Pharmaceutical Sciences (2011) and a PhD degree in Pharmaceutical Sciences (2017) from UAntwerpen. During her IWT-funded PhD research, she concentrated on investigating drug resistance and therapeutic failure in patients with leishmaniasis. Following the completion of her PhD, she assumed the role of research manager at the Neurovascular Center of the Antwerp University Hospital. In this capacity, she was tasked with establishing and expanding a research line within this center. As a scientific coordinator, she actively managed research projects, initiated research collaborations, identified new funding opportunities, organized scientific symposia, and supervised both Master and PhD students. Her personal research project delved into exploring the interaction between the bacterial microbiome and intracranial aneurysms. Known for inspiring students with her passion for science, she combined her job as research manager with a position as lecturer in the Pharmaceutical Technical Assistant education program at KISP. Annelies has a particular interest in infectious diseases, which led her to work as a postdoctoral researcher at the Institute of Tropical Medicine Antwerp. During this time, she coordinated a clinical study investigating clinical prognostic factors for therapeutic failure in leishmaniasis patients and provided support within the FA5 capacity-building program in Ethiopia. She is currently working at the Global Health Institute and the Antwerp University Hospital (UZA). She serves as the scientific coordinator for the FiLi-Vi-X project, which aims to prepare first-line healthcare workers in the Flemish healthcare system for 'virus X.'

​Vincent Rennie​

PhD (Open University, United Kingdom), senior bioinformatician, Department of Family Medicine and Population Health, Faculty of Medicine and Health Sciences. Vincent is a evolutionary microbiologist and bioinformatician with a keen interest in  applying Next-Generation sequencing (NGS) to study Mycobacterium tuberculosis. He is currently working on the valorization of the MAGMA pipeline developed by Lennert Verboven and Tim Heupinck. He is particularly interested in transforming this academic software into a user-friendly platform for clinicians using the principles of design thinking and user-experience (UX) design practice. Together with Sequentia Biotech, he is working to develop a gold standard web platform that will be submitted for endorsement by the WHO and subsequently rolled out worldwide to facilitate the implementation of WGS for treatment of dug resistant TB cases, thus improving the treatment outcomes of hundreds of thousands of patients worldwide.

​Josefien van Olmen​

Emmanuel Rivière​

​PhD student, Department of Epidemiology and Social Medicine, Faculty of Medicine and Health Sciences. Emmanuel is a biomedical scientiest with a background in molecular and cellular biomedical science. He has an interest in analysis of Next Generation Sequencing data and bioinformatics in general. His research focuses on drug resistance mechanisms in Mycobacterium tuberculosis as part of the Center for Whole Genome Sequencing of Mycobacterium tuberculosis.

​Sander Goossens​

Sander completed his Master of Science in Genetics, Cell and Development Biology at the Vrije Universiteit Brussel in 2014. The three subsequent years he worked as a Biology and Physics teacher at the International Montessori School of Brussels. In October 2018 he started his PhD at the faculty of medicine and health sciences at the University of Antwerp. He will use whole genome sequencing and RNA sequencing data in order to respectively investigate the within-host MTB population dynamics and MTB transcriptional responses under drug pressure. Next he is also studying the effect of epigenetic modifications in MTB under drug pressure.

​Lennert Verboven​

Lennert graduated as MSc in computer science at the faculty of science at the University of Antwerp in 2017. He has a background in data mining and machine learning and an interest in bioinformatics. He is currently working on a PhD at the faculty of science at the University of Antwerp. He joined the Centre for Whole Genome Sequencing of Mycobacterium tuberculosis where he applies his data mining and machine learning skills to improve knowledge regarding MTB transmission dynamics and emergence of drug resistant TB.

​Ynke Larivière​

PhD student, Centre for Evaluation of Vaccinations (CEV) & Global Health Institute (GHI), University Antwerp. Ynke Larivière graduated as Master in Epidemiology in 2019. She started working as Assistant Project Manager in March 2019 for the EBL2007 clinical trial as part of the EBOVAC3 project at the CEV and GHI, at the University of Antwerp. The phase 2 clinical trial has been set up in Boende, Democratic Republic Congo, to test a two-dose heterologous, prophylactic vaccination regimen against Ebola virus disease which is in development by Janssen Vaccines & Prevention B.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson with the goal to bring the vaccine to licensure. Since April 2020 Ynke has started her PhD, where she focusses on the immunogenicity and safety of the two-dose heterologous, prophylactic vaccination regimen against Ebola virus disease.

​Gwen Lemey​

PhD student, Centre for Evaluation of Vaccinations (CEV) & Global Health Institute (GHI), University Antwerp. Gwen Lemey graduated as Master in African Languages and Cultures in 2005 and in International Affairs and Diplomacy in 2006. She started working for the Global Health institute as a Project Coordinator in 2013, since when she is responsible for donor-funded research projects in Central and East African countries. Since 2019 she is working on an Ebola vaccination trial with the Janssen Ebola vaccine, implemented in collaboration with the University of Kinshasa, DR Congo. Since 2022 she started a PhD trajectory, whereby she specifically works on research ethics and the topic of Ancillary Care of research conducted in resource-constrained settings.

​Alessandro Grosso​

Alessandro is a PhD Student in Medical Statistics at the Global Health Institute (University of Antwerp), under the supervision of Prof. Steven Abrams, Prof. Niel Hens, and Prof. Koen Peeters (Institute of Tropical Medicine). His PhD project focuses on advancing statistical methods for the estimation of relevant age/time dependent epidemiological malaria parameters, accounting for sources of observed and unobserved heterogeneity. Additionally, he is interested in the use of Network Analysis as a novel approach for the development of malaria elimination strategies. Alessandro holds a MSc in Economic and Social Sciences from Bocconi University (Milan), and has worked in the past as a Research Fellow in Health Economics within the Team for Economic Evaluation and Health Technology Assessment (TEEHTA) at the Centre for Health Economics of the University of York (UK).

​Amber Hadermann​

Amber is a PhD student with a background in Biomedical sciences of tropical and infectious diseases (MSc, 2021) and Tropical Medicine (MSc, 2022). Her interests are parasite (gen)omics and bioinformatics. She is working on a project focusing on the disease mechanism of Onchocerciasis Associated-Epilepsy (OAE) at the Global Health Institute and Center For Proteomics.

Aimée Julien Suárez​​

​Mahdi Safar Pour

Mahdi completed his Master of Science in Biotechnology in 2012. He graduated as Master in Epidemiology from the faculty of Medicine and Health sciences, University of Antwerp in 2022. He has a background in genetic epidemiology and machine learning. Since May 2022, Mahdi is working on a PhD project at the Department of Family Medicine and Population Health, University of Antwerp. His research focuses on investigating malaria transmission dynamics by integrating epidemiological and travel data with whole genome sequencing data of malaria parasite. 

​Luís-Jorge Amaral

Luís has a background in epidemiology (MSc at Imperial College London) and microbiology (BSc at Portuguese Catholic University and University College Cork). He worked as a Biomedical Scientist at the UK Health Security Agency and as an Epidemiologist Consultant at Imperial College London, where he is currently a Visiting Researcher. In April 2022, Luís started his PhD at the Faculty of Medicine and Health Sciences at the University of Antwerp, where he is focusing on reducing the onchocerciasis burden. This is being achieved by recognising the burden of the disease, particularly from onchocerciasis-associated epilepsy, and tailoring the control interventions to prevent it. Tanzania, South Sudan and Togo are some countries where his PhD research takes place.

​Maha Salloum

PhD candidate at the Global Health Institute (GHI) and the Centre for Evaluation of Vaccinations (CEV). Her research focuses on investigating community perceptions surrounding the Janssen Ebola vaccine and the EBL 2007 clinical trial in Boende, DR Congo, as well as examining the attitudes and confidence in childhood vaccinations. She is a pharmacist with a master's degree in Vaccinology and her research interests include vaccine confidence, seroepidemiology, and migrant health.

Geoffrey Manda​​​

Geoffrey Manda, MBBS, M.Sc., holds a Master of Science in public health from the London School of Hygiene and Tropical Medicine, University of London in the United Kingdom, and is now a PhD candidate focusing on infectious disease modelling at the Global Health Institute, Faculty of Medicine and Health Sciences, University of Antwerp. His strengths lie in mathematical epidemiology and biostatistics, as well as health economics, with a focus on encapsulating public health challenges into mathematical tools and economic evaluations to investigate the epidemiological and economic impact of various infectious disease control interventions to support evidence-based public health decision-making.

Miguel de Diego Fuertes

Miguel is a MSc Biotechnology & Bioinformatics graduate from the University of Aberdeen, Scotland, and his main interests are centered around the increasingly concerning problem of antibiotic resistance and its impact on global health. He joined the Center for Whole Genome Sequencing of Mycobacterium tuberculosis in 2022, and is currently exploring the approaches and tools that bioinformatics and data science can offer for addressing these issues.

​Pham Hien Trang Tu​

Trang Tu is a pharmacist and epidemiologist, with a background in clinical epidemiology and pharmacoepidemiology. She completed her Master of Epidemiology at University of Antwerp in 2022 and since then joined the Center for Whole Genome Sequencing of Mycobacterium tuberculosis. Her research focuses on applying advanced epidemiological methods to study the value of NGS in optimizing drug-resistant TB treatment and precision public health.

​Annelies Boven​

Annelies Boven has a background in epidemiology (MSc at the University of Antwerp) and biomedical sciences (BSc at the University of Amsterdam). She finished her Master of Epidemiology in 2022 and has since worked with professor Nele Brusselaers on projects related to C. difficile infections. She is currently involved in the Global-PPS project and focuses on antimicrobial consumption and stewardship in specialist outpatient care.  

Gwen Lemey​

• VLIR-UOS TEAM Tanzania
• EBOVAC3
  

​Paul Peter Vermeiren​​

• EBOVAC3
• SEMA-REACT

​Tafadzwa Maseko​

• Datamanager Sema-React

​Ellen Van Himbergen​

• VLIR-UOS funded projects
• Global PPS, DRIVE-AMS, and related projects
• FiLi-Vi-X
• FWO Peru
  
• GHI website and social media

​Evodia Uggi​

• EBQ course
• Master of Epidemiology VLIR-UOS scholarships

Catherine De Witte

• CityMove
  

​​Dimitri Geelhand de Merxem

An overview of all our current Sandwich PhD students and their research topic can be found here.